Persivia, a leader in advanced digital health platforms, has secured a substantial $107 million investment from Aldrich Capital Partners while simultaneously receiving U.S. Patent No. 12,254,975 B2 for its Health Data Processing System. This dual achievement represents a significant milestone for both the company and the healthcare industry as Persivia positions itself to scale its AI-first CareSpace® platform.

The investment, finalized in late February, provides Persivia with the capital needed to accelerate growth across multiple fronts: enhancing platform innovation, strengthening client success initiatives, and expanding market presence. This comes at a critical time when healthcare organizations are seeking technological solutions to improve care delivery while managing the transition to value-based payment models.

At the core of Persivia's offering is the newly patented Soliton® AI engine, which powers the company's modular CareSpace® digital health platform. Unlike traditional healthcare platforms that primarily display data, Soliton® takes a more proactive approach by ingesting, analyzing, prioritizing, and delivering actionable insights in real time. This functionality enables healthcare teams to:

• Respond efficiently to the most urgent patient needs

• Manage complex patient populations more effectively

• Streamline clinical workflows through a single unified interface

The CareSpace® platform features a modular architecture designed specifically to support healthcare organizations transitioning from fee-for-service to value-based care models. This flexibility allows organizations to implement specific solutions according to their needs, spanning data management, care coordination, quality improvement, population health management, analytics, virtual care, and risk adjustment.

Looking ahead, Persivia plans to significantly expand its sales force over the next year while developing new AI-powered solutions. These initiatives aim to enhance operational efficiency and patient management capabilities for healthcare organizations across the country.

"This isn't just a win for Persivia, it is a great day for US healthcare as a whole," said Dr. Mansoor Khan, CEO of Persivia. "With the industry-leading platform, new capital and a newly issued patent, we're ready to deliver on a vision that's been 20 years in the making—solving healthcare's toughest challenges with an AI core that is now patented, proven, and deployed at scale."

The combination of significant funding and patent protection positions Persivia to potentially reshape how healthcare organizations leverage AI to improve patient outcomes while navigating the complexities of modern healthcare delivery and reimbursement.

Click here for the original news story.